Using Wilcoxon test, we further investigated the expression level of ANTXR1 in different clinicopathological features of GC patients and found that its level significantly correlated with T stage (P < 0.0001), AJCC stage (P < 0.001), Lauren classification (P < 0.0001), WHO grade (P < 0.05), tumor size (P < 0.05), and race (P < 0.05) based on the TCGA dataset (Figures 1C–H). Here, ANTXR1 is linked to gastric cancer.